RxDoctor Payments Data

Richard Boe, MD

Adult Reconstructive Orthopaedic Surgery · Austell, GANPI 1013327642

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (29.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 36.6% of the total. 2025 is the largest year on record at $16,093, more than ten times the $1,258 reported in 2019.

$39,939in general payments, 2019–2025

Across 144 payments — averaging $277.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$15K
  • Heron Therapeutics, Inc.$13K
  • Medical Device Business Services, Inc.$9K
  • Stryker$2K
  • Johnson & Johnson$473
  • Medacta USA, Inc.$331
  • plus $791 from 9 others

What the payments were for

  • Consulting fees$7,67419%
  • Speaking & faculty fees$11,60029%
  • Travel & lodging$11,86330%
  • Food & beverage$8,80322%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,939 in reported general payments places this provider in the 80th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$216,119
Medicare patients
369
Services billed
12,987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib414$6,907
Diclofenac Sodium284$3,649
Cefdinir128$1,630
Ondansetron OdtOndansetron132$1,121
Oxycodone Hcl154$757
Ibuprofen51$494
Meloxicam77$370
Gabapentin83$332
Methylprednisolone53$275
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$194
Cyclobenzaprine Hcl32$154
Amoxicillin61$150
Tramadol Hcl34$104
Tizanidine Hcl21$68
Clindamycin Hcl11$38

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Austell

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →